Session Details

Advanced Practice Professionals (APP track) Session 1 – Cord-Blood Derived Therapies for Regenerative Medicine, Transplantation & Cancer Immunotherapy
Thursday, May 30, 2019 11:00 AM - 12:15 PM
Room 217
Megan Cornelison, MS, PA-C, MD Anderson Cancer Center, USA
Tobi Fisher, MPAS, PA-C, MD Anderson Cancer Center, USA

This session will discuss the benefits of cord blood transplantation and ex vivo expansion in allotransplantation, and the novel use of cord-blood derived iPSCs (immunologic Pluripotent stem cells).  We will also be discussing CAR T-cell and gene therapy development and manufacturing.

Cord Blood Transplantation for Hematologic Malignancies: Do We Need Expansion?
Juliet Barker, MBBS, Memorial Sloan Kettering Cancer Center, United States

Generating GMP-grade iPSCs from Banked Cord Blood for Potential Regenerative Therapy Purposes
Ngaire Elwood, PhD, Murdoch Children's Research Institute, Australia

CAR-T Cell and Gene Therapy Development and Manufacturing
David DiGiusto, PhD, Semma Therapeutics, United States